Condition

PROC clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• MUC16-targeted antibody-drug HWK-016 for advanced ovarian and endometrial cancer

  This will test HWK-016, an antibody-drug that targets MUC16, in adults with advanced or metastatic ovarian or endometrial cancer, including platinum-resistant ovarian cancer.

  Recruiting at 9 sites Phase 1 Whitehawk Therapeutics, Inc. · Little Rock, Arkansas and 11 other locations · NCT07470853

• HWK-007, a PTK7-targeted antibody‑drug conjugate for advanced PTK7-positive ovarian, endometrial, and certain non‑squamous lung cancers

  This study will try HWK-007, a PTK7-targeted antibody‑drug conjugate given every three weeks, to see if it can shrink or control advanced PTK7-positive ovarian, endometrial, or non-squamous EGFR wild-type lung cancers.

  Recruiting at 10 sites Phase 1 Whitehawk Therapeutics, Inc. · Little Rock, Arkansas and 11 other locations · NCT07444814

Related topics

Quick answers

How many PROC clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →